{
  "id": 4205496,
  "name": "Mary and Thomas DANIEL, Respondents v. WYETH PHARMACEUTICALS, INC. Wyeth-Ayerst Pharmaceuticals, Inc., Wyeth-Ayerst International, Inc., Wyeth Laboratories, Inc., Wyeth Pharmaceuticals, Div. of Wyeth, Div. of American Home Products Corp., Wyeth Inc. a/k/a American Home Products Corp., Petitioner",
  "name_abbreviation": "Daniel v. Wyeth Pharmaceuticals, Inc.",
  "decision_date": "2011-12-05",
  "docket_number": "Nos. 818 EAL 2011, 319 EAL 2011",
  "first_page": "217",
  "last_page": "217",
  "citations": [
    {
      "type": "official",
      "cite": "613 Pa. 217"
    },
    {
      "type": "parallel",
      "cite": "32 A.3d 1260"
    }
  ],
  "court": {
    "name_abbreviation": "Pa.",
    "id": 8832,
    "name": "Supreme Court of Pennsylvania"
  },
  "jurisdiction": {
    "id": 6,
    "name_long": "Pennsylvania",
    "name": "Pa."
  },
  "cites_to": [],
  "analysis": {
    "cardinality": 115,
    "char_count": 1221,
    "ocr_confidence": 0.719,
    "pagerank": {
      "raw": 4.5046715916883656e-08,
      "percentile": 0.2824525676979623
    },
    "sha256": "6bb438fabbd69726d34b859e70d308810c14424ed20c91314ff70dc772ea5a8a",
    "simhash": "1:117bd73963dde507",
    "word_count": 193
  },
  "last_updated": "2023-07-14T17:04:25.190284+00:00",
  "provenance": {
    "date_added": "2019-08-29",
    "source": "Harvard",
    "batch": "2018"
  },
  "casebody": {
    "judges": [],
    "parties": [
      "Mary and Thomas DANIEL, Respondents v. WYETH PHARMACEUTICALS, INC. Wyeth-Ayerst Pharmaceuticals, Inc., Wyeth-Ayerst International, Inc., Wyeth Laboratories, Inc., Wyeth Pharmaceuticals, Div. of Wyeth, Div. of American Home Products Corp., Wyeth Inc. a/k/a American Home Products Corp., Petitioner."
    ],
    "opinions": [
      {
        "text": "ORDER\nPER CURIAM.\nAND NOW, this 5th day of December, 2011, the Petition for Allowance of Appeal is GRANTED, LIMITED TO the issue set forth below. Allocatur is DENIED as to all remaining issues. The issue, as stated by Petitioner, is:\nWhether the Superior Court erred in reversing the trial court\u2019s grant of JNOV for Wyeth on [Respondents\u2019] punitive damages claim under Pennsylvania law, where (a) the FDA extensively reviewed and approved the prescription drug at issue, the sufficiency of the testing for that drug, and the drug\u2019s label warnings of the risk of breast cancer, (b) there was no evidence that Wyeth concealed information from or misled the FDA or knew that the risk of breast cancer was greater than disclosed in its warnings, and (c) the drug was extensively tested and studied by Wyeth and independent researchers?",
        "type": "majority",
        "author": "PER CURIAM."
      }
    ],
    "attorneys": [],
    "corrections": "",
    "head_matter": "32 A.3d 1260\nMary and Thomas DANIEL, Respondents v. WYETH PHARMACEUTICALS, INC. Wyeth-Ayerst Pharmaceuticals, Inc., Wyeth-Ayerst International, Inc., Wyeth Laboratories, Inc., Wyeth Pharmaceuticals, Div. of Wyeth, Div. of American Home Products Corp., Wyeth Inc. a/k/a American Home Products Corp., Petitioner.\nSupreme Court of Pennsylvania.\nDec. 5, 2011.\nNos. 818 EAL 2011, 319 EAL 2011."
  },
  "file_name": "0217-01",
  "first_page_order": 275,
  "last_page_order": 275
}
